BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32749865)

  • 1. Parkinson's: A Disease of Aberrant Vesicle Trafficking.
    Singh PK; Muqit MMK
    Annu Rev Cell Dev Biol; 2020 Oct; 36():237-264. PubMed ID: 32749865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
    Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
    Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
    Daher JP
    Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the endolysosomal system in Parkinson's disease.
    Vidyadhara DJ; Lee JE; Chandra SS
    J Neurochem; 2019 Sep; 150(5):487-506. PubMed ID: 31287913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.
    Teixeira M; Sheta R; Idi W; Oueslati A
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Sheehan P; Yue Z
    Neurosci Lett; 2019 Apr; 697():59-65. PubMed ID: 29627340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease.
    Gao Y; Wilson GR; Stephenson SEM; Bozaoglu K; Farrer MJ; Lockhart PJ
    Mov Disord; 2018 Feb; 33(2):196-207. PubMed ID: 29315801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPS35, the Retromer Complex and Parkinson's Disease.
    Williams ET; Chen X; Moore DJ
    J Parkinsons Dis; 2017; 7(2):219-233. PubMed ID: 28222538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
    Ryan BJ; Hoek S; Fon EA; Wade-Martins R
    Trends Biochem Sci; 2015 Apr; 40(4):200-10. PubMed ID: 25757399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological Functions of LRRK2 in Parkinson's Disease.
    Jeong GR; Lee BD
    Cells; 2020 Nov; 9(12):. PubMed ID: 33266247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endosomal sorting pathways in the pathogenesis of Parkinson's disease.
    Cunningham LA; Moore DJ
    Prog Brain Res; 2020; 252():271-306. PubMed ID: 32247367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation.
    Bae EJ; Lee SJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165632. PubMed ID: 31812666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2-Related Parkinson's Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis.
    Rivero-Ríos P; Romo-Lozano M; Fasiczka R; Naaldijk Y; Hilfiker S
    Front Neurosci; 2020; 14():556. PubMed ID: 32581693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.